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1. General role of the regenerative medicine and dentistry
In many scientific centres, the World intensive research is under way related to the significant
development of science in the field of Materials Engineering in connection with cell biology,
thus expanding the new groups of advanced materials and technologies finding their applica-
tion in regenerative medicine and dentistry. The author has already published on this topic
studies [1–4] as well as books [5–9], monographs [10–24], scientific papers [25–76], patents [77–
84] awarded in international fairs and exhibitions of research, invention and innovation [85–
102]. In this area, several of author’s own scientific and research projects have also been
realised [103–107]; some are in progress [108], and others are planned for implementation
[109]. Generally, one of the main reasons of this activity is the dynamic growth of post-injury
defects, post-resection defects, as well as those originating from the operative treatment of
cancerous tumours, whereas the number of cases is systematically increasing, or inflammation
processes and as a result of other disorders of the human population, including the conse-
quences of tooth decay, in particular due to local and systemic complications. Surgical treat-
ment, often saving human lives, causes the necessity to replace losses in such organs or tissues,
including in the dental system, to prevent biological and social degradation of patients and to
restore their living functions. A growing number of road accidents and severe injuries of more
and more people frequently requires a surgical intervention with replacement or supplemen-
tation of losses in organs or tissues and numerous interventions in the stomatognathic system.
For example, the data of the Association for Improving Safety of Road Traffic reveal that about
1.7 million people suffer injuries in the EU every year. The growing number of sports accidents
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and bodily injuries frequently requires a surgical intervention with supplementation of lost
tissues, also in the dental system. For example, according to EU IDB catalogue, annually, an
average 6.1 million people in the EU are treated in hospitals for sports injuries. The number
of people aged over 65 will have systematically grown, e.g., in EU by 70% to 2050. System-
atically proceeding population ageing, which considerably increases the number of patients
requiring surgical intervention with supplementation of losses in organs or tissues, often in
the stomatognathic system.
One of the fundamental tasks globally, considered also to be one of the European Union’s
priorities, is to improve the society’s condition of health, medical care and health safety. The
numerous tasks related to this topic include the prevention of health risks, early recognition of
diseases, rapid and effective implementation of medical procedures, comprehensive and con-
tinued therapies leading to an improved health condition and the improved health condition
and improved quality of the society’s life [1]. For example, the European Health Strategy
regards health-related aspects to be a central focus of the Community’s policy and proposes a
programme of actions for citizens, by recognising their right to own health and healthcare and
through the promotion of the ageing society’s health, through the protection of citizens against
risks for their health and life and through supporting dynamic health care systems and new
technologies, related to technical support for medicine, including dentistry. The idea is to
protect against serious health risks, especially such as civilisational diseases, pandemics and
bioterrorism and to support research, especially such applying advanced technologies, to
ensure the fullest prophylactics of diseases and safe treatment of patients, taking into account
the relationships between health and economic well-being. A significant and costly problem of
modern medicine is the necessity to replace or supplement organs or tissues, in particular in
orthopaedics and traumatology and maxillofacial surgery and restorative dentistry, to prevent
the biological and social degradation of patients and to restore their living functions [1]. It also
applies mostly to the elimination of consequences of tooth decay, considered to be an excep-
tionally burdensome civilisational disease, also one of the costliest ones, in particular, due to
local and systemic complications [110–125].
A relatively new branch of medicine is regenerative medicine and dentistry. The achievements
of modern implantology depend not only on the knowledge and experience of medicals, but it
also requires the application of advanced engineering problems, both in the field of engineer-
ing design, material engineering, nanotechnology and material technology. These are very
responsible research, and the most avant-garde trends concern the offering of personalised
medical devices manufactured according to individual anatomical features of the patient,
according to complex and advanced original technologies and ever newer biomaterials used
for implantable devices. These issues are the subject of many years of scientific interest of the
Author, and they belong to the group of the most avant-garde, so far relatively little known,
but extremely promising technical problems for use in regenerative medicine and dentistry.
This study presents the results of previous studies and own research, derived from previously
published original own work done by the Author with a team of co-workers [1–19]. As in all
other cases, in material engineering and material science, in order to satisfy the functional
functions of implantable devices as well as all other products, it is necessary to design and
apply engineering materials that, subjected to the appropriate technological processes of
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shaping the geometric form, and especially the structure, will ensure appropriate physico-
chemical properties of the material. This book presents exhaustively the achievements of
numerous teams from different countries of the world, inscribing itself in the discussed Euro-
pean Health Strategy, in advanced research areas related to biomaterials used in regenerative
medicine and dentistry. In the overall analysis of the issue concerning biologically active
cellular structures and a substrate with an engineering composite material matrix used for
scaffolds and for newly developed implantable devices applied in regenerative medicine and
dentistry, further in this description all the aspects are analysed separately, because the lack of
holistic approach and general references is in the literature, apart from own works.
2. Importance of regenerative medicine and dentistry and tissue
engineering
The development of regenerativemedicine, whose technical aspects are covered by the bookwith
the first reports dating back to 1992 [126], is a relatively new field of medicine. Implantable
biomedical devices encompass numerous solutions eliminating various dysfunctions of a human
organism and are currently aggregately considered to be medical bionic implants. The develop-
ment of regenerative medicine, whose technical aspects are covered by the book, previously
described in author’s theoretical study [1], started with the first reports dating back to 1992
[126], as a relatively new field ofmedicine. Implantable biomedical devices encompass numerous
solutions eliminating various dysfunctions of a human organism and are currently aggregately
considered to be medical bionic implants. Bionics is understood as production and investigation
of biological systems to prepare and implement artificial engineering systems which can restore
the lost functions of biological systems [127, 128]. Autographs, allografts or metal devices or such
made of other engineering materials are primarily the current methods of organ and tissue
replacement employ [129]. The purpose of the regenerative medicine is treatment—by replacing
old and sick cells with young cells, also using tissue engineering methods and cell-based thera-
pies or organism regeneration using a gene therapy. It raises numerous new challenges, notably
in counteracting the symptoms and consequences of diseases, and even their causes [130–133].
The application of therapies based on living cells inmedicine is a relatively new concept. The first
successful allogeneic transplantation of human haematopoietic stem cells (HSC) was seen as late
as in 1968 [134] (29), then the cells were used for other therapeutic applications [135, 136]. The
therapies based on living cells were intensively developed in the 1990s [137], in particular for skin
and cartilage implants. Tissue engineering provides technical support for regenerative medicine
and is an interdisciplinary field employing the principles of engineering and life sciences for
development of biological substitutes, for restoration, maintenance and improvement of func-
tions of tissues or entire organs [138, 139]. Tissue engineering, introduced in 1985 [140], as a field
of technical sciences, utilises medical knowledge and materials engineering methods to develop
biological materials capable of restoring, maintaining or improving the functions of particular
tissues or organs [138] and to produce their functional substitutes [141, 142]. Tissue engineering is
based on understanding the principles of tissue growth and on applying this for functional
production of a replacement tissue for clinical use [143].
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An overview of the present situation points to a diversity of the currently available therapeutic
methods based on cells, undergoing the phase of clinical studies [144]. The global market of
cell-based therapies boasts a revenue of more than a billion USD per year [145]. Therapeutic
strategies include direct transplantation of the desired type of cells collected using biopsy or
such originating from cultures of stem cells, both in the autologous and allogeneic system.
Multipotent and self-renewing stem cells (MSCs), depending on the tissue development stage,
can be grouped into adult and embryonic cells [136, 146, 147]. Embryonic cells exist in umbil-
ical cord blood [148, 149], in the placenta [150], in amniotic fluid [151] or deciduous teeth pulp
in infants, termed as multipotent stromal cells (MSCs). The clinical application is most benefi-
cial, especially of autologous cells [136], as they do not cause an immunological response and
do not require immunosuppressive treatment [151–154], and, nevertheless, such application is
limited [155]. There is a much greater potential for somatic and especially haematopoietic stem
cells (HSC) from bone marrow stromal [156–158], supporting bone marrow stromal cells
(BMSCs) as a standard [136, 158]. Adult stem cells also occur, in particular, in synovial fluid,
tendons, skeletal muscles [158, 159] and adult muscles, fat tissue—ASCs (adipose-derived
stem cells ASCs) [158, 159], the stroma of cornea [149], peripheral blood, nervous tissue and
dermis and have an ability of transformation into multiple tissues.
The efficiency of cell-based therapies depends on the preservation of their viability after
implantation [160, 161], to prevent the ischaemia of tissues and necrosis [162–167]. Stem cells
originating from bone marrow and fatty tissue may be used for breeding mesenchymal cells
and tissues, in adipocytes, chondrocytes, osteoblasts and skeletal myocytes and can be used for
producing tissues, e.g., muscles fat, gristle and bones [168–171]. Stringent safety requirements
must be considered in cell-based therapies because raw materials of the animal origin are used,
which poses a potential threat of transmitting a pathogen to a recipient or of immunological
complications [172] and as post-production cleaning is required [173]. Progress in this domain
seen since 2004 requires further detailed considerations concerning the mechanism of in vivo
therapeutic activity, to facilitate the development and optimisation and for the development of
automated processes, with improved efficiency and with quality control and with reference
standards established [174–177]. About 100 companies specialised in this area are operating at
the American and European market. For better characterisation, the conditions of cell-based
therapies must be realised more intensive the basic research. The introduction of the new
clinical regenerative procedure having no competition requires the development of breeding
techniques of human stem cells. However, the adult stem cells could be used to a limited extent
[178]. The fabrication of the majority of therapeutically meaningful cell types (except the
mesenchymal stem cells) has not yet been mastered at a technologically satisfactory scale.
However, it should be emphasised that the outcomes achieved to date in this area be promis-
ing. Therefore, a wide commitment of the scientific environment is generated for the elabora-
tion and explanation of the phenomena accompanying the growth of tissue structures in
conditions allowing their industrial production. The purpose is the development of the ade-
quately organised therapeutic processes, introduction appropriate engineering materials and
obtaining the technological processes for them, including nanotechnology. A very important
cognitive task is the explanation the interaction between the surface structure of engineering
materials forming the substrate and the tissue structures deposited onto it and explication the
role of a substrate for culturing tissue structures.
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Opposite to pure therapies, in which stem cells are injected directly into peripheral circulation
or located in particular tissues, in numerous clinical cases it is necessary to use stem cells’
carriers to transport them, and especially scaffolds for their three-dimensional grouping in a
particular place of an organism, and such research is being constantly developed [179–188]. It
should be noted that the notion of scaffolds is quite comprehensive, as it may not only refer to
engineered extracellular matrices ‘scaffolds’, but also to rigid microporous materials into
which osteoblasts may grow, and also to microporous mats made of polymer nanofibres, into
which living cells are growing and may be used as specific plasters, to treat for example burns
or to reconstruct large fragments of skin [7]. The latest publications [5, 6] also note the
relevance and need of developing such therapeutic methods for the dental system. A micro-
scopic, porous structure of scaffolds is required, enabling the diffusion of nutrients and metab-
olism products through them. Scaffolds, including also bone scaffolds, must enable the
adhesion and migration of cells and facilitate their development to form a three-dimensional
tissue structure in conditions simulating a natural micro-environment [187, 189]. Scaffolds
should exhibit adequate mechanical properties for ensuring an appropriate environment of
development for cells and ensure the mechanical preservation of living tissues in a three-
dimensional structure. The task of scaffolds is to ensure also the necessary conditions of cells
growth by the creation of new blood vessels [190–193].
Two separate aspects need to be considered: a porous structure, especially the size of pores and
manufacturing technologies of appropriate porous materials, and the selection of engineering
materials of which scaffolds are produced. Both aspects are of primary importance for the
undertaking’s success, and hence each of them has been analysed based on the state-of-the-art.
3. Designing of geometric properties of porous materials
Porous materials have been used for not too long in orthopaedic procedures to replace dam-
aged bones, and porous scaffolds are geometrically similar to natural hard tissues made up of
a skeleton penetrated by interlinked pores [194], thus solid metals are unsuitable because they
are, by nature, non-permeable and prevent the adhesion and proliferation of living cells.
Porous materials, mainly metals, are implanted to repair damaged bones having a critical size
and in the majority of cases are used as carrying devices [195]. It is vital that an implant has
properties similar to a recipient bone and the surrounding tissue [196]. A human bone has a
hierarchical structure with three major anatomic cavities of different sizes which are Haversian
canals (50 μm) [197], osteocytic lacunae (few micrometres) [198–201] and canaliculi (<1 μm)
[201, 202]. All the three cavities play an important role in the mechanical integrity of the bones
and the processes reconstruction [203]. A porous structure ensures appropriate space for the
transport of nutrients and the growth of living cells [204, 205]. A bone elasticity modulus,
much smaller than for non-noble metals, is regarded to be one of the major problems in the
construction of implants because, as a result, the screening of stresses would often lead to
implant damages. Porous metals can duplicate bone properties if their structures are digitally
designed and are produced using advanced manufacturing technologies [205]. A bone, despite
its anisotropy [206], is being replaced by porous engineering materials with similar rigidity,
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making them efficient for transmitting loads and for alleviating the effect of stress screening
and for regeneration of bone tissue in the damaged place [195]. The following is therefore
required: (1) biocompatibility; (2) appropriate surface for adhesion, proliferation and differen-
tiation of cells; (3) a very porous structure with a network of open pores for the growth of cells
and for the transfer of nutrients and metabolic wastes; (4) mechanical properties adjusted to
the requirements of the surrounding cells to reduce or eliminate excessive stresses and meeting
anatomic requirements to avoid a mechanical damage [207–211]. The key features for the
design of porous metallic implants include careful selection of porosity, size of pores and
mutual connections between pores, aimed at achieving satisfactory clinical results. Such con-
structional features have a large effect on the mechanical properties and biological activity of
scaffolds [195]. Bone regeneration in vivo porous implants consists of recruitment and penetra-
tion of cells from the surrounding bone tissue and vascularisation [212]. Higher porosity may
facilitate such processes and enable bone growth [213, 214]. The influence of the pore size on
the growth of cells, e.g., bone cells, is, however, still controversial [195, 215]. Pore sizes of
artificially produced scaffolds should be adapted to the specific cell type. They should be
small, because then they ensure more space for cells’ growth, e.g., bone tissue [195], but small
enough to prevent the sealing of pores in a scaffold [187]. They should also be large enough to
prevent blood clots [216], enable the migration of cells and ensure conditions to fill up scaffold
pores by the reconstructed cells, guaranteeing neovascularisation [217]. For this reason, the
upper suggested limit is 400 μm [215], because it is no longer beneficial to increase it. It was
found, though, that for pores sized 600–900 μm, the growth of bone cells is higher than for the
pores sized 300 μm [195]. The permeability of a porous structure of a scaffold ensures the
transport of cells, nutrients and growth factors as a result of blood flow, and a blood pressure
gradient depends on the pore size and has also influence on vascularisation and accelerates the
osseointegration process [195], although this requires further studies. It is thought that the
optimum pore size for cells growth, and especially mineralised bone growth, is 100–400 μm
[195]. The aspect is still important, because although increased porosity, pore size and mutual
connection of pores are the key factors, which are having a large impact on facilitated bone
growth and the transport of cells and nutrients, evidently ameliorating the quality of biological
processes, nevertheless they may considerably reduce rigidity and strength of scaffolds [195].
Although the shape and size of pores can be adjusted by changing the conditions of even
traditional fabrication processes, e.g., casting or powders metallurgy; however, only a ran-
domly organised porous structure can then be obtained, which is not fully open or is not open
at all [218]. To produce porous scaffolds as well as other medical implants, including dental
ones, additive technologies are used most often in combination with prior CAD/CAM, as
highly competitive against traditional manufacturing methods, such as casting or machining
[219–224]. Such technologies can be applied for various engineering materials, not only metals
and alloys which are prepared, respectively, as powder or liquid, rolled material or thin fibres.
Additive technologies have been widely used for fabricating diverse, customised elements
applied in medicine, in particular, scaffolds with required porosity and strength with living
cells implanted into an organism [225–227], models of implants and dental bridges [228–230],
implants of individualised implants of the upper jaw bone, hip joint and skull fragments
[231–238]. Considering the additive technologies applied most widely, the following have
found their application for scaffold manufacturing, in implantology and prosthetics, i.e.,
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electron beam melting (EBM) [222, 239–243], and also 3D printing for production of indirect
models, although selective laser sintering/selective laser melting (SLS/SLM) and its technolog-
ical variants offers broadest opportunities [220, 222, 244–253], which was noted in discussing
each group of materials. SLS/SLM techniques permit to produce a structure with open pores,
e.g., with a lattice structure promoting osseointegration, while maintaining different external
shapes of the whole implant [254]. The determination of optimum geometric features of scaf-
folds as a result of computer-aided design in conjunction with the optimisation of technolog-
ical conditions of the applied additive technology, and broad experimental verification in the
engineering and biological aspect, is of key importance.
4. Selection of materials of implantable devices in regenerative medicine
and dentistry
The selection of appropriate materials for application in the regenerative medicine and den-
tistry, in conjunction with the optimisation of technological conditions of fabrication of
implantable devices, including porous scaffolds and implant-scaffolds, are the important
aspects of the analysed problems, previously just described in author’s own theoretical study
[2]. It occurs as a synergy of classical prosthetics/implantation of bone and organ post-injury or
post-resection losses together with the methods of tissue engineering in the connection (inter-
face) zone of bone or organ stumps with prosthetic elements/implants. It calls for the use of
porous and high-strength non-graded metal and/or composite and/or polymer materials
(which is strongly, but not exclusively, dependent on the specificity of the clinical application)
together with using at the same time biodegradable materials for tissue scaffolds. One of the
solutions strives to achieve bioactive connections, as most advantageous regarding bond
strength, which is formed between bone tissue and implants/scaffolds made or coated with
bioactive materials, considerably improving the stability and durability of connection, espe-
cially for porous scaffolds/implants. Another acceptable approach is a very durable biological
connection characteristic for porous implants/scaffolds whereby the bone tissue is growing
through the material pores and is mechanically “anchored” in the bone. Porous resorbable
bioglass may be used for scaffold fabrication [255], e.g., from the CaO-SiO2-P2O5 system,
Hench bioglass [256], produced both, with classical melting methods and with sol-gel
methods, and also bioglass from the SiO2-Al2O3 system endowed with silver, due to their
biocompatibility [257, 258] and bacteriocidity, and with pore walls coated with hydroxy car-
bonate apatite (HCA) [259], ensuring enhanced activity of osteoblasts [260] and expression of
genes connected with bones [261]. The formation methods of porous structures from ceramic
materials, in particular such as aluminium oxide, zirconium oxide, calcium carbonate, hydroxy-
apatite (HA), titanium oxide, include casting of sections from mass containing a fine-grained
ceramic material with additives facilitating foaming and then material sintering, and also the use
of other methods, e.g., an organic matrix and lyophilisation of ceramic slip [255]. The basic
bioactive ceramic materials used for scaffolds is calcium phosphate (CaPs), as the main compo-
nent of bone, and in hydroxyapatite (HA), β-tricalcium phosphate (β-TCP) or a mixture of HA
and b-TCP, known as biphasic calcium phosphate [262–264]. A classical solution in the domain
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of ceramics, are porous scaffolds/corundum implants completely biocompatible, growing
through the fully valuable bone tissue. They possess mechanical strength sufficient for many
types of clinical procedures and ensuring freedom of manipulation during a surgical procedure.
After growing through, have an appropriate modulus of elasticity, which ensures their good
interworking with the bone and also allow for sterilisation with any method. Both, bioactive and
biodegradable polymers can be employed [193, 265, 266], including in particular natural poly-
mers such as: alginate, chitosan, collagen, fibrin, hyaluronic acid and silk, and used, e.g., for bone
reconstruction [267], as well as synthetic ones, such as poly(lactic acid) (PLA), poly(glycolic acid)
(PGA), and polycaprolactone (PCL) and poly(propylene fumarate) (PPF) with high compressive
strength, comparable to this of a cortical layer of bone [266]. Some of them, such as poly(lactic
acid) (PLA), poly(glycolic acid) (PGA) may cause negative tissue reactions [268]. Composite
materials satisfy mechanical and physiological requirements, e.g., CaP-polymer scaffolds,
interconnected tricalcium phosphate (TCP) scaffolds coated inside pores with polycaprolactone
(PCL) [269], hydroxyapatite HA/poly(ester-urethane)(PU) [270] or a nanocomposite of collagen
and Bioglass [271].
Metallic materials represent one of the largest groups of engineering materials used for this
purpose and comprise, among others, titanium, tantalum, niobium and their alloys, and in
dentistry also cobalt-matrix alloys and alloys of noble metals, for which, SLS/SLM technologies
were especially applied [272, 273], irrespective of stainless steels often used until now. The SLS/
SLM technique has been used successfully for production of complex porous and cellular
structures made of austenite stainless steels [218]. One of the main grades of stainless austenitic
steel which can be used for medical purposes is nickel, now thought to be one of the main
allergens [274], with 17% of adults [275] and 8% of children [276] being sensitised to it, approx.
50–60 million people altogether in the EU. Apart from many disorders [277, 278], this chemical
element causes rejection of orthopaedic gradients [279], and dental implants [280] and, for this
reason, Directive 94/27/EC [281] was put into force prohibiting the use of nickel and materials
containing it for prosthetic and implantological purposes. Co-matrix alloys such as Co-Cr-Mo,
Co-Cr-W and cast Co-Cr-W-Mo alloys, for machining or manufactured by powder metallurgy
methods, for which the SLS/SLM technology was successfully employed [272, 273, 282–289],
can be seen as the basic classical materials for dental prosthetic restorations [290–296], despite
their high density, which is more and more often considered as counter-indicative for their
application for such purposes.
Porous metal materials, though not biodegradable, are used for scaffolds, mainly Ti and Ta
[297], also after treatment of pores’ surface [298]. Therefore, interest in light metals and their
alloys have been on the rise. Ti and its alloys represent engineering materials which are
particularly suitable for use in additive technologies, e.g., for selective laser sintering [5, 6, 10,
77–81, 85–91, 299–305]. Porous Ti [297] can be utilised for non-biodegradable scaffolds, includ-
ing such after treatment of the pore surface, applied primarily due to relatively high compres-
sive strength and fatigue strength [193, 306]. It was proven that structures of porous Ti6Al4V
are also effective in aiding the growth of cells and bone tissue [307–311]. Ti and its alloys
with Al, Nb and Ta and Ti alloys with Al, V and Nb, well tolerated by a human organism,
are the metallic materials more and more often used these days for joint prostheses and for
various implants, also intramedullary wires and for prosthetic restorations and dental
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implants [33, 312–322]. When used for dental crowns, though, they have a significant disad-
vantage, consisting of porcelain reactions with titanium oxide, causing bruising and colour
darkening, which - for aesthetic reasons - practically eliminates such prosthetic restorations,
but does not exclude their use for a root part of the implant [323]. Titanium-matrix materials do
not cause allergic reactions and are stainless and feature high strength and hardness, and also
thermal conductivity several times lower than traditional prosthetic materials [324]. Titanium is
a very thrombogenic material [240]. The biocompatibility, especially thrombocompatibility, of Ti
can be enhanced by introducing alloy elements [325]. Some publications [326–334] provide
limited information on the toxic activity of V as an alloy element in the Ti6Al4V alloy, because it
was found that V could be regarded as a potentially toxic factor [335, 336], which is, however,
true only for a considerable concentration of V in a body, due to development of its undesired
immunological response, when the freed V ionsmigrate from thematerial surface to a soft tissue,
binding with proteins [337, 338]. Some research on cells implies that Ti6Al4V exhibits high
cytotoxicity [307–311, 339]; there are reports that V may cause sterile abscesses, and Al may
cause scarring, while Ti, Zr, Nb and Ta show good biocompatibility [340]. Some publications
argue that a risk associated with an unfavourable effect of Ti alloys can be limited by replacing V,
as in, e.g., Ti6Al4V alloy, by Nb, e.g., in Ti6Al7Nb alloy, which would show better properties,
e.g., corrosion resistance and bioavailability [334, 341–346]. It was revealed, however, by direct
comparison in the same conditions that differences between Nb and V in Ti alloys are not too
high [334], and even that Ti6Al4V alloys exhibit better properties than Ti6Al7Nb alloy [334, 347–
349], such as thrombocompatibility, more intensive antibacterial activity and resistance to colo-
nisation of Gram-positive bacteria, although worse for colonisation of Gram-negative bacteria
[334]. Other alloys, with a higher concentration of Nb, are however employed successfully, e.g.,
Ti24Nb4Zr8Sn, including those manufactured by selective laser sintering, with an elasticity
modulus better adapted to a bone than Ti6Al4V alloy, which prevents bone resorption and does
not cause implant loosening in use [350]. Although porous Ti6Al4V was comprehensively
studied, the potential release of toxic ions has led to a search for alternative Ti alloys, including,
among others, Ti24Nb4Zr8Sn, Ti7.5Mo and Ti40Nb, with comparable mechanical properties as
their counterparts manufactured traditionally [350–353].
The concept of the synergic use, for this purpose, of the existing achievements in tissue
engineering in the scope of selection of materials and scaffold fabrication technologies, in
materials engineering and production engineering in the scope of design and manufacture of
prostheses/implants with different engineering materials, and in surgery and regenerative
medicine in the scope of prosthetics/implantation in the treatment of the above-mentioned
civilisational diseases and their effects have been outlined in the earlier works and projects by
the author [1–109].
Regeneration in a natural condition is forcing the removal of an artificial scaffold [354–356].
The topic of scaffolds and biodegradable implants, including porous ones, both made of poly-
mers [193], despite doubts of Mg-Ca alloys [357], and of composite materials [269–271], as well
as a concept of separating the redundant pieces of cell-based products after finishing a therapy
performed with their use [7], were thoroughly analysed in the own works [5, 6, 10]. Relatively
high compressive strength and fatigue strength [193, 306] are primarily the reason for the
application of Mg and its alloys [358–360]. Introducing pure Mg with interconnected porosity
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onto bearing plates, bolts and networks made by rapid pressure assisted densification
methods, such as rapid hot pressing/Spark Plasma Sintering (SPS) is an innovative approach
[361]. Due to Mg biocompatibility, and the manufacturing technology ensuring good mechan-
ical strength and recovery of the bone pure Mg gives an optimum solution. Mg with Ca, Zn
and Mn alloys can be used, to reduce the rate of in vivo corrosion and prevent necrosis and the
blocking of blood flow. A human organism well tolerates these alloys [362, 363] mainly with
coatings adapted to bioresorbable implants [364–367]. Reinforcements of magnesium MMCs
usually include, notably, HA [368–373], FA [374], calcium polyphosphate [375], and calcium
[374] and well affect biocompatibility. Mg and its alloys can be used for non-biodegradable
scaffolds [372]. Except for several studies, the application of Mg as a biomaterial has not won
popularity as late as until the end of the 1990s, because this pure metal cannot ensure appro-
priate mechanical properties or corrosion resistance in orthopaedic uses [376, 377]. Such
popularity, though, has risen exponentially since then [378], owing to major improvements in
Mg production [378] and various techniques elaborated, including the use of Mg alloys,
substrate surface treatment or coating technologies [379–381]. Generally speaking, such alloys
contain Al or rare-earth elements (REE) [382–384], although there are reports about studies
over additives of non-toxic elements, such as Ca, Mn, Zn and Zr, and even Li, Cd, Sn, Sr., Si,
Ag and Bi [378]. Al is a common additive for Mg alloys, as it is conceded that it improves
strength and resistance to Mg alloys’ corrosion Mg (258), although Al is shown in numerous
pathological conditions in humans [385–388]. The additives of rare-earth elements are used for
increasing strength, plasticity and wear resistance of Mg alloys and their corrosion resistance
[383] in environments with a high content of chlorides in connection with a passivation layer
rich in oxygen [389, 390]. The influence of such elements on the physiological system is
unknown, [378], although it was found that they possess both, anti-carcinogenic and anti-
coagulation properties [391], and when used as vascular stents without side effects [392], and
also without La and Ce, do not have an effect on cytotoxicity and have a positive effect on
cellular life [393], although quite the opposite was also found, that at least some REEs are
highly toxic [393, 394]. The value of the research carried out in this scope may be limited if it
turns out that such elements are too toxic in use for biomaterials [377] and this requires further
systematic studies. Magnesium synthesised by SLM is closely adapted to a human bone [395].
This technology was employed for producing complex porous/cellular structures of magne-
sium alloys [350, 396–398], although the results of such studies are normally not available in
the available literature [254]. A selective laser sintered Mg2Mn alloy is predisposed to use for
bone implants [254]. The use of Mn, as a component of Mg alloys, consists of the improvement
of corrosion resistance and may increase the plasticity of Mg alloys [383, 399]. Zn improves the
strength of Mg alloys [399, 400] and their corrosive resistance [401]. However, its influence on
increased cytotoxicity was identified [402, 403]. Magnesium and its alloys feature a high
potential for orthopaedic uses because it has proven to be fully bioresorbable, their mechanical
properties are adapted to bones and do not cause an inflammatory response; moreover, they
are osteoconductive, supportive to bone growth and play a positive role in the binding of cells
[404]. The application of biomaterials made of Mg highly increases a risk of hypomagnesia
and, probably, of the excessively stored and circulating Mg [378]. Corrosion analysis and Mg
concentration monitoring in serum must be an important aspect of Mg-based biomaterials’
assessment [378]. Due to an effect of diverse factors such as pH, concentration and type of ions,
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adsorption of proteins on orthopaedic implants and the biochemical activity of the surround-
ing cells in the presence of body fluids [405, 406], further research into biomedical uses of Mg is
indispensable. Powders are serially manufactured for, in particular, SLS/SLM [407].
Third-generation scaffolds made of CaP, Si-TCP/HA [408] and collagen hydrogel [409] are
osteoinductive and allow to create a new bone and also its biomineralisation. Substitute scaf-
folds of bones are often administered with medicines, including gentamycin, vancomycin,
alendronate, methotrexate and ibuprofen [410, 411] and with growth factors and transcription
factors [265, 412, 413].
5. Selection of technologies of implantable devices in regenerative
medicine and dentistry
The issue was previously considered in the Author’s own review work [2], and some of the
information compiled there was used here. The traditional, and also the oldest fabrication
technologies of scaffolds with a porous structure differentiate the method of emulsifying/
lyophilisation [414], to thermally induced phase separation (TIPS) [415], solvent casting &
particulate leaching (SCPL), where solvent residues may have an adverse effect on cellular
structures [416]. The aforementioned classical methods being unable to control accurately a
general shape of the scaffold as well as the size, shape, distribution and interconnections of
pores. Nevertheless, these methods have not been completely abandoned. They are used as a
modern method in tissue engineering replication technologies with micro-/nanopatterned-
surfaces [417–419]. The master moulds are produced using a hard or soft material,
for the reason of mould rigidity. The structures with small feature resolution and micro/
nanofabricated moulds, including for hot embossing (also known as nanoimprint lithography)
and soft lithography (micro-casting) for achieving patterns with dimensions about of 5 nm
[420–423] can be cast using synthetic and natural biodegradable polymers [424, 425]. Currently
used methods do not require moulds for fabrication of scaffolds (solid freeform fabrication
SFF) made not only polymer materials and hydrogels but also ceramic and metallic materials
[193, 426–429]. The particular fabrication methods find wide application for the processing
both the mentioned biocompatible engineering materials and biological materials [430]. The
particular layers of powder are sprayed with an adequate biocompatible binding agent, e.g.,
for merging powder to fabricate scaffold from collagen [431], and a 25% acrylic acid solution in
a mixture of water with glycerine [432] using the three-dimensional printing method (3DP)
[433]. This method is also used for the integration of hydroxyapatite used for bone regenera-
tion, and an aqueous citric acid solution is used for integration of ceramics based on calcium
phosphate [434]. A method of three-dimensional printing hot wax droplets [435] could be used
for manufacture a replica of the scaffold surface, e.g., bone and gristle substitutes fabricated
with the SFF method. The limitations of the method originate from wax impurities with
biologically incompatible solvents [436], which are not exhibited by new generation materials
such as BioBuild and BioSupport dissolving in ethanol or water [436]. The stereolithography
method permits to shape three-dimensional form of liquid polymer [437], in particular using
poly(propylene fumarate) (PPF) [438, 439], poly(ethylene glycol) (PEG) [440, 441]. Polymer
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materials without solvents, including poly(ε-caprolactone) PCL [429, 442], poly(ethylene gly-
col)–poly(ε-caprolactone)–poly(lactide), PEG-PCL-PLA [442, 443] acrylonitrile-butadiene-sty-
rene (ABS) and hydroxyapatite-poly(ε-caprolactone) HA-PCL [442, 444] are used in fused
deposition modelling (FDM) [445]. The particular layers are placed from a computer controller
and using computer-aided design (CAD) methods. Selective laser sintering (SLS) is similar to
3D printing. The process is starting with uniform spreading of a thin layer of powder onto the
surface and then followed by the merging of powder grains as a result of sintering with the
neighbouring grains with partial pre-melting. The next layers are manufactured subsequently
according to the same method until the full dimensions of the manufactured element are
achieved. The manufactured element, including the scaffolds, shows the assumed construc-
tional features. This technique, used commonly for additive manufacturing of products,
includes scaffolds and implants for the dental purpose, from metallic and ceramic materials
[5, 6, 10, 446]. This technology was also utilised for scaffolds preparation [426] from biode-
gradable polymers, e.g., polyether polymer, poly (vinyl alcohol), polycaprolactone [447] and
poly(L-lactic acid) [448], and also hydroxyapatite [449] and from composites composed of
some of such polymers and hydroxyapatite [448, 450, 451].
Nanofibrous scaffolds are manufactured by electrospinning, and the so obtained nanofibres with
the diameter of 5 nm to over 1 mm are continuous and randomly interconnected [452, 453]. Due
to the character of electrospinning, fibres are arranged in an orderly manner or are oriented
randomly [454]. They have a large specific surface area, exhibit high porosity, the small size of
pores and small density [453] and their structure is similar to the extracellular matrix (ECM).
Natural and engineering materials can be used as a material, including, in particular, collagen,
gelatin and chitosan [453]. Scaffolds are fabricated using of non-covalent interactions for sponta-
neous fabrication of a three-dimensional structure in response to the activity of environmental
factors [455]. The ability of peptides and nucleic acids, to self-organisation, is utilised for scaf-
folds fabrication. Such types of scaffolds were used, e.g., for regeneration of nervous tissue to
stop bleeding and repair infatuated myocardia, as well as in medical products for slow release of
a medicine [456, 457] and for DNA, where the branched DNA particles are hybridisingwith each
other in the presence of ligases in hydrogel [458]. The scaffold fabrication method employing
self-organisable nanofibres is one of few allowing to produce biocomponents with their proper-
ties similar to the natural extracellular matrix (ECM), and scaffolds containing hydrogel, made
using such technology, employ more advantageous toxicological properties and higher biocom-
patibility than traditional materials. Conventional hydrogels are particularly useful for three-
dimensional placement of cells [459]. Hydrogels used in tissue engineering should have low
viscosity before injection and should be gelling fast in the physiological environment of the
tissue, and the most important is gelling (sol-gel transition) by cross-linking, which may take
place when producing them in vitro and in vivo during injection. Physical cross-linking is used in
particular in the case of poly(N-isopropylacrylamide) (poly(NIPAAM)), which may be used in
tissue engineering after introducing acrylic acid (AAc) or PEG [460, 461] or biodegradable poly-
mers, including such as chitosan, gelation, hyaluronic acid and dextran [462–466] to block
copolymers, such as poly(ethylene oxide) PEO-PPO-PEO (Pluronic), poly(lactide-co-glycolide)
PLGA-PEG-PLGA, PEG-PLLA-PEG, polycaprolactone PCL-PEG-PCL and PEG-PCL-PEG [467–
471], and also agarose (a polysaccharide polymer material, extracted from seaweed as one of the
two principal components of agar) [459], as thermo-sensitive systems [472], to avoid the use of
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potentially cytotoxic ultraviolet radiation. Poly(NIPAAM) and block copolymer hydrogels may
undergo cross-linking as a consequence of temperature and pH acting at the same time, as in the
case of acrylates [473, 474], such as 2-(dimethylamino)ethyl-methacrylate (DMAEMA) or 2-
(diethylaminoethyl) methyl methacrylate. Self-assembling peptides hydrogels, including such
containing peptide amphiphiles (PAs), can form nanofibres [475, 476] used for three-dimensional
formation of tissue cultures [476–480].
Chemical cross-linking hydrogels having convalescent bonds include photo-cross-linkable
poly(ethylene glycol)-diacrylate (PEGDA), poly(ethylene glycol)-dimethacrylate (PEGDMA),
poly(propylene fumarate) (PPF) and oligo(poly(ethylene glyco) fumarate) (OPF) [481–485],
and also natural hydrogels such as dextran, alginate, chitosan and hyaluronic acid synthesised
from PEGDA/PEGDMA [486–489] and Michael-type addition reaction [490–492] and Schiff
base-cross-linked hydrogels [465, 493–495]. In the case of enzyme-mediated cross-linking
[458], transglutaminases (including Factor Xllla) and horseradish peroxidases (HRP) [459] are
used for the catalysis of star-shaped PEG hydrogels [496] and tissue transglutaminase
catalysed PEG hydrogels [497]. This also applies tyrosinase, phosphopantetheinyl transferase,
lysyl oxidase, plasma amine oxidase, and phosphatases [498]. It made it possible in particular
to develop new gels by engrafting tyramine groups into natural and synthetic polymers such
as dextran, hyaluronic acid, alginate, cellulose, gelatin, heparin and PEG-PPO [499–505, 509].
Ionic cross-linking hydrogels include calcium-cross-linked alginate [459] and chitosan-
polylysine, chitosan-glycerol phosphate salt and chitosan-alginate hydrogels [506–508]. Different
synthetic and natural polymers were used for this purpose, including polyethylene glycol (PEG),
and copolymers containing PEG [486, 510], hyaluronic acid (HA) [511] after an oxidation reac-
tion through HA-tyramine conjugates [505] and as a result of the formation between HA–SH
[492, 512] and Michael addition [491, 513], collagen and gelatin hydrogels mostly cross-linked
using glutaraldehyde, genipin or water- soluble carbodiimides [513–515], chitosan [516–519],
dextran 192 [520, 521] and alginate [522]. Hydrogels were used for reconstruction of the retina
[523], ligament [524], fatty tissue [465], kidneys [525], muscles [526], blood vessels [527, 528], and
also heart, neural cells, invertebral discs, bones and gristle [459]. Hydrogels were used to prevent
adhesions [529, 530, 531], to promote cellular adhesion [490, 532, 533]. So-called strong hydrogels
were developed to improve mechanical properties [534]. The three-dimensional representation is
possible of placement of cells with energy in the hydrogel to vascular structures using a laser
[535, 536], notably for recording directly the endothelial cell [535].
The general criteria of materials selection for tissue scaffolds relate to the material type and its
structure, osteoconductivity ability, mechanical strength, ease of production andmanipulation in
clinical applications. Table 1 presents numerous examples of the application of various bioactive
and engineering materials, and their respective materials processing and tissue engineering
technologies for manufacturing of the hybrid personalised implants and scaffolds [2].
Many layers of different types of cells at present can be three-dimensionally printed to directly
create an organ, ensuring the highest currently possible degree of control over the structure of
the regenerated tissues [537–542]. The first production system for three-dimensional printing
of tissues was delivered only in 2009 based on the NovoGen bioprinting technology [543]. China
has invested nearly 0.5 billion USD to establish 10 national institutes for development of organ
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printing [544], in which the printing of ears, liver and kidneys from living tissues was started in
2013. It is expected that fully functional printed organs can be achieved over the next dozens of
years or so [545, 546]. In the meanwhile, there were reports that an Australian team obtained a
kidney tissue print with this method for the first time [547]. An American team confirmed in
2014 it is ready to print a heart [548]. A three-dimensional structure is obtained by subsequent
formation of layers of living tissues on the gel or sugar matrix substrate [549]. To use the three-
dimensional printing technique, a polymer-cell mixture can be dosed, leading to the formation of
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Table 1. Examples of the application of various bioactive and engineering materials, and their respective material
processing and tissue engineering technologies for manufacturing of the hybrid personalised implants and scaffolds [2].
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cell hydrogel [550]. Microfluidics allows for the creation of three-dimensional systems of cells
[551]. It is possible to obtain such cell systems from hydrogels by photopolymerisation of
polymer solutions [552]. Using SFF techniques, including stereolithography techniques can
create scaffolds made of PEG hydrogels also [440]. Vascularisation for organ printing remains a
significant challenge in tissue engineering. The development of a vascular network in metabol-
ically functional tissues enables the transport of nutrients and removal of wastes, ensuring
maintenance of cells’ viability for a long time [553]. Micro-formation techniques, by the three-
dimensional printing of templates made of agarose fibres, are used for the creation of a
microchannel network inside hydrogel products, including, in particular, inside star poly(ethyl-
ene glycol-co-lactide)acrylate (SPELA), methacrylated gelatin (GelMA), poly(ethylene glycol)
dimethacrylate (PEGDMA) and poly(ethylene glycol) diacrylate (PEGDA) with different con-
centrations. In the last several years, the efficient formation of endothelial monolayers within the
fabricated channels has also been confirmed [554]. Unfortunately, the progress in vascularisation
control is limited, despite immense progress in the production of complicated tissue structures.
6. Contents of the book on regenerative medicine and dentistry
The book on Biomaterials in Regenerative Medicine contains a total of 18 chapters. Selected
issues discussed in the previous five sub-chapters were presented in it. The literature review, in
this first chapter, deals with technical, biological and medical aspects concerning materials and
technologies for medical and dental implantable devices. In the second chapter, the metallic
biomaterials and their application in regenerative medicine are presented in detail by the
literature review. In addition to these two chapters, all the rest contain the results of their
scientific research done by the authors of these chapters. Indeed, the originality of the
presented research results constitutes the real value of the book at this moment passed to the
readers’ hands. The next chapters contain issues about additive technologies and laser
manufacturing of materials used in regenerative medicine and mainly in regenerative den-
tistry. The third chapter is on microporous titanium-based materials located inside the pores by
biocompatible thin films to facilitate the implantation and proliferation of living cells in the
scaffolds thus produced. In turn, the fourth chapter includes mechanical properties compari-
son of engineering materials produced by additive and subtractive technologies for dental
prosthetic restoration application. It discusses both solid and milled sintered titanium and its
alloy, Co-Cr alloy, and sintered ZrO2. In the fifth and sixth chapters, properties of Co-Cr dental
alloys fabricated using an additive, technologies were presented. The progress of the applica-
tion of 3D printing for tissue regeneration in oral and maxillofacial surgery is presented in
chapter seven. In the eighth chapter, the issues of the tissue engineering and use of growth
factors in bone regeneration are discussed. Laser processing was analysed in chapter nine
concerning silicon for its synthesis as better biomaterials. Prospective of characterisation of
the skin models and associated with it measurements and simulation of permeation and
diffusion in 3D tissues are presented in the tenth chapter. The eleventh chapter also contains
the skin regeneration problems explanation and also a description of the biomaterials for
tendon and ligament regeneration. The next few chapters deal with natural and artificial gels
of polymeric materials. In the twelfth chapter, authors described the hydrogels for regenerative
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medicine. Natural rubber latex biomaterials in bone regenerative medicine are presented in the
thirteenth chapter. A systematic study of ethylene-vinyl acetate (EVA) in the manufacturing of
protector devices for the orofacial system was described in the fourteenth chapter. The next
few chapters outline other issues regarding regenerative medicine and tissue engineering. The
fifteenth chapter includes tailoring bioengineered scaffolds for regenerative medicine. Bioma-
terials and stem cells as promising tools in tissue engineering and biomedical applications are
the content of the sixteenth chapter. Identification of Fe3O4 nanoparticles biomedical purpose
by magnetometric methods is the title of the seventeenth chapter. The eighteenth chapter
applies to biomaterials for tissue engineering applications in diabetes mellitus.
The editor, publisher and the whole team of authors, by making this book available to the
readers, deeply believe that the detailed information collected in the book, largely deriving
from own and original research and R&D works pursued by the authors, will be beneficial for
the readers to develop their knowledge and harmonise specific information concerning these
topics, and will convince the engineers and medicals about the advantages of using the
manufacturing and tissue engineering and advanced biomaterials in regenerative medicine
and dentistry. On one hand, it makes possible gaining positive effects in the economic
manufacturing of biomaterials and implantable devices; on the other hand, it will ameliorate
the fate of many people affected by severe diseases. This awareness justifies the involvement in
the execution of research and the effort put in describing their results in this book.
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